Hanahan Police Department launches new at-risk resident database
Hanahan At-Risk Residents Table (HART) provides a way for the police department to keep the community safe. As officials cite over 20% of children are affected by neurodiversity and seven million adults live with Alzheimer's or dementia in the United States. Those numbers boiled down to the city equals over 8,000 residents who may live with these effects.
'What implemented this was just recently we had an individual at a residence, who was elderly, suffering from some sort of medical condition that wandered away from his residence twice in a day. So, that was kind of the catalyst to push this out as fast as we could,' Rick Gebhardt, police chief of Hanahan, said.
The entries are uploaded on a platform that only law enforcement can access. Friends and family can upload information and photos of their loved ones at any time.
'This is a way for citizens to enter information on loved ones from their name, their address, their date of birth, physical descriptors, locations they like to frequent, medications, and medical history,' Gebhardt said. 'So, we can better respond to them and provide them with assistance.'
Though, the department has been looking to get a database like this off the ground for a couple months. In the case of a missing person, officers can now respond quickly and efficiently.
'We've been trying to get something like this implemented for a while – just with the 'Just Bee' training that we had a few months ago from the Just Bee Corporation. We just saw the need to have the database where families can enter this information that we can have access to at the tip of our fingers at any call, to help share the information in a more efficient manner,' Gebhardt said.
Hanahan Police said you may contact them by phone or by email on the city's website.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
New drug could halt Alzheimer's
A new drug could halt the progression of Alzheimer's disease. Trials suggest the treatment, called trontinemab, could be the most powerful weapon yet against dementia. Research will now examine whether the drug should be given to those without any symptoms in order to prevent the disease. Results presented at the Alzheimer's Association International Conference in Toronto found the 'game-changing' treatment can clear the devastating plaques associated with Alzheimer's far more rapidly than any current licensed drug. Nine in 10 patients prescribed trontinemab experienced amyloid clearance within 28 weeks, meaning visible markers of disease had vanished. Experts hope these changes will be matched by improvements in memory and functioning, with an 18-month trial of 1,600 patients now under way. Separate research will examine whether the drug could be given to people without any signs of dementia, in the same way that statins are used to ward off heart disease. On Monday, experts said the findings were 'very promising', suggesting that the drug was much more powerful than existing medications, with far fewer side effects. Around one million people in the UK suffer from dementia, with Alzheimer's disease the most common form. Powerful precise effects at low doses Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials suggest that, in less than seven months, it has outperformed the ability of existing drugs to clear plaques in 18 months. Experts hope that if given early enough, the drug could save some patients from developing symptoms at all. It has been engineered to more easily cross the blood-brain barrier, meaning it can ensure powerful precise effects at low doses. The lack of side effects means it could be offered to large populations. This also means it could be offered at a far lower price than current medications, which require intense monitoring, including regular scans. Experts believe it could become the first Alzheimer's drug to be funded by the NHS. Last year, medicines regulators in the UK gave the green light to the first two treatments found to slow progression of Alzheimer's disease. Both lecanemab and donanemab use monoclonal antibodies to clear amyloid plaques in Alzheimer's disease. In trials they have been found to slow decline by 27 per cent and 35 per cent respectively, over 18 months. However, the risk of brain swelling and brain bleeds means they need intense monitoring. The new drug appears to have a far better safety profile. The phase two trial of 149 patients found less than five per cent of cases suffering amyloid-related imaging abnormalities, and all cases quickly resolved. It also requires less frequent infusions, with mass trials to examine the impact of giving the drug to patients once a month for six months, then every three months. Scientists have been intrigued by the promise of trontinemab because of the way it has been designed to be transported across the blood brain-barrier, which normally prevents chemicals in the bloodstream from entering the brain. 'Game-changing' Prof Sir John Hardy, the chairman of molecular biology of neurological disease at University College London's Institute of Neurology said the advance could be 'game-changing'. He told The Telegraph: 'This is absolutely great news. It sucks the plaque out of the brain really quickly, much faster than we have seen with lecanemab or donanemab.' The scientist, who was the first to identify the role of amyloid in the disease, said the drug's safety profile was a 'massive improvement' on the current drugs on the market, raising hopes it could be used both to prevent disease and stop it in its tracks. He said: 'There is no doubt this could be game-changing. We hope that if we can use these drugs to people early, we can halt the progression of disease, even before people have symptoms. Now we need to see the size of the clinical effect.' Neither of the current drugs have been funded by the NHS as a result of their high costs, much of which stems from the need for intense monitoring, including regular scans. Prof Hardy said: 'These results show it is much faster and safer than previous drugs, which means less monitoring. That brings down the cost significantly, it means fewer MRI scans, so that would surely mean it would get Nice [National Institute of Health and Care Excellence] approval.' 'Very promising evidence' Prof Jonathan Schott, the chief medical officer at Alzheimer's Research UK said: 'We urgently need a range of treatments for Alzheimer's that are effective and safe for the people affected by this devastating disease. 'Evidence presented at the Alzheimer's Association conference in Toronto on trontinemab is very promising, showing that the drug can effectively and rapidly clear amyloid from the brain, seemingly with very few side effects. 'We now need to see whether these early stage results carry through to later stage clinical trials, which are planned to start later this year, including in the UK. These trials will show whether the drug is not only safe, but impacts on memory, thinking and quality of life.' He said it was 'exciting' that the drug would now be tested in some people without symptoms under the phase three trials. Levi Garraway, Roche's chief medical officer said: 'Combining new treatment avenues with advanced diagnostics may enable earlier and potentially more effective intervention. 'With plans for phase three trials in both early symptomatic and preclinical Alzheimer's disease, we are advancing science with the goal of delaying – and ultimately preventing – progression of this devastating condition.'
8 hours ago
ABC News Live Prime: July 29, 2025
New details in NYC mass shooting; new study in the advance of Alzheimer's research; 170 million Americans under heat alert; "Jeopardy!" host Ken Jennings discusses new trivia book.
Yahoo
9 hours ago
- Yahoo
NYC Gunman Blamed This Rare Brain Disease For His Mental Illness
On Monday night, a gunman killed four people and himself in Manhattan in an attack that reportedly targeted the NFL's headquarters in the city. The gunman, Shane Tamura, left behind a note in which he said he'd been suffering from chronic traumatic encephalopathy, or CTE, as a result of playing football. He had asked for his brain to be studied as part of CTE research. The discourse about football's impact on the brain is not new to the NFL. Both players and their families have sued the league time and time again over the matter of brain damage and its effects on players' post-career lives. CTE is a 'progressive neurodegenerative disease,' explained Dr. Jeremy Tanner, an assistant professor of neurology at the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio. Research shows that football players, along with other people who participate in high-contact sports and activities, are more likely to develop the disease. A study out of Boston University's CTE Center found 40% of athletes under 30 had developed early signs of the disease upon their death. Another study out of BU found that roughly 91% of studied NFL players had the disease when they died. Experts told HuffPost that CTE research is ongoing, but there are clear links between head injuries, behavioral changes and the disease itself. Here's what to know: What is CTE? Like other brain diseases, such as Alzheimer's disease or Parkinson's disease, CTE affects how we think, behave, move and 'really anything that the brain is responsible for,' said Dr. Daniel H. Daneshvar, the co-director of Mass General Brigham Sports Concussion Clinic. 'It occurs in patients that have sustained traumatic brain injury, so blows to the head that may or may not have resulted in concussions,' said Dr. Aaron S. Lord, the chief of neurology and program director for clinical research at NYU Langone Hospital–Brooklyn. The more head injuries that occur, the higher the risk of developing chronic traumatic encephalopathy, Lord added. The thought pattern used to be that concussions increased CTE risk, but this isn't the case, added Daneshvar. 'Concussions themselves aren't what drives CTE risk. It's a repeated traumatic brain injury to the tune of hundreds or thousands over the course of decades that... increases the risk of someone having CTE,' he said, adding that the number of traumatic brain injuries also affects the severity of the disease. Can someone be diagnosed with CTE? You can't walk into a doctor's office and get a diagnosis of CTE. Right now, it can only be diagnosed after death, during an autopsy, said Lord. That means that people who may or may not have CTE can still get a gun license, a fact that can get lost in the discourse on social media about Tamura carrying the weaponry he had. The New York Police Department reported he had a 'documented mental health history,' but it's unclear if this would restrict his gun access. People who play contact sports are at higher risk — but any activity that involves frequent head impact is a risk factor. Specifically, CTE has been identified in players who engage in contact sports such as football, rugby, hockey and rodeo, said Tanner, adding that it's also been seen in soccer players. 'And it seems... the more total years played, the higher the risk,' Tanner said. It often is developed over time, after someone stops playing the sport, or the head trauma ends, explained Tanner. Daneshvar added that 'we've also seen [it] in individuals who experience intimate partner violence, in individuals who serve in the military.' Again, Daneshvar notes, the more often the head injury happens, the higher the risk of CTE. 'Famously, in the literature, there was a circus clown who was repeatedly shot out of a cannon and who was found to have CTE,' he said. CTE can cause behavioral changes and memory problems. 'Chronic traumatic encephalopathy [is] typically associated with changes in cognition and in behavior,' said Tanner. 'In behavior, a common symptom is what's called neurobehavioral dysregulation. For some people, this can present as a shortened fuse or more or irritability or agitation,' Tanner said. For others, this can mean paranoia, aggression, impulse control issues and trouble regulating emotions, he added. Neurobehavioral dysregulation tends to be more common in 'those affected by the disease in younger stages,' Tanner noted. 'Additionally, chronic traumatic encephalopathy is associated with changes in memory and with executive function, particularly planning, organization, multitasking... managing information and integrating it.' 'And those symptoms seem to be more common in older adults with the disease,' he added. It's important to note that a lot of these symptoms can also be signs of other neurological disorders or mental health diseases, said Tanner. In the end, individuals with a CTE diagnosis had problems with thinking, memory and behavior, said Daneshvar. But, once again, these things can be related to a multitude of other issues. 'We can't say for sure what clinical signs someone presents with are related to CTE pathology versus something else because humans are complex. We have a lot of different reasons for the way we behave,' said Daneshvar. If you do notice mental health changes, memory issues or other neurological problems, Tanner advises people to see a specialist for an evaluation. 'It's often a neurologist or a psychiatrist or a sports medicine specialist who has expertise in evaluating those with repetitive head impacts in sports,' Tanner said. 'It can be hard to distinguish what's the primary cause, and so looking at the number of years of head impact exposure can be a clue that there could be an increased risk for CTE.' Seeking medical attention for any neurological changes is essential, whether you're dealing with CTE or not. 'I see individuals who have histories of repeated traumatic brain injuries and are experiencing problems now, and I can't say with certainty whose problems are related to CTE versus not... but what I can do, and what I do every day, is treat them, and our treatments for people's symptoms are successful,' said Daneshvar. While there is no cure for CTE, doctors can still help, Daneshvar noted. 'I think that's a really important message, too. I think people think that CTE is some incurable, immovable thing, right? And it is treatable.' CTE has been linked to violence in some cases, but not always. ″In some cases, [CTE] has been linked to violent and aggressive behaviors,' Tanner said. One of the most talked about cases of CTE is that of Aaron Hernandez, a deceased former football player who was convicted of murder. 'The short fuse, the impulse control. One way to think about it could be when you're playing sports, you can turn [your aggression] on and off. You lose that ability to control the 'on and off' switch you use to regulate your aggression when on the field and off the field,' Tanner explained. There are some things you can do to lower your risk of CTE. As mentioned above, people who take part in particular sports or activities, such as football and rugby, are at higher risk of CTE. But there are a few habits that can help protect your brain. Lord added that wearing a helmet — whether that's on a bike ride or while playing football — is also an important way to protect yourself. Tanner suggests that instead of playing tackle football, try playing flag or touch football. 'We have a lot more to learn about how to prevent this disease,' Tanner said. 'What I would suggest is trying to minimize, as much as [you're] able, head contact and head impacts.' 'For former football players and others, there's the new Diagnose CTE study that's really looking at trying to understand how we can identify these symptoms during life and better understand this disease,' Tanner said. The study is actively recruiting former football players to learn about the unknowns of the disease. If you or someone you know needs help, call or text 988 or chat for mental health support. Additionally, you can find local mental health and crisis resources at Outside of the U.S., please visit the International Association for Suicide Prevention. Related... NYC Gunman Reportedly Left Note Blaming Specific Factor For His Mental Illness Gunman Opens Fire In Manhattan Office Building, Killing 4
